BGLC vs W · rev $9.5M vs rev $11.85B
BioNexus Gene Lab Corp Common stock (BGLC) versus Wayfair Inc (W) — a side-by-side from cached financials, not a winner call.
BioNexus Gene Lab Corp Common stock (BGLC) is a specialty chemicals company listed on NASDAQ.
Wayfair Inc (W) is a internet retail company listed on NYSE.
Latest reported BGLC revenue for 2024-12-31 was $9.5M. Net income was $1.6M. Revenue was down 2.7% from 2023-12-31 to 2024-12-31. BGLC currently screens at market cap $6.1M.
Latest reported W revenue for 2024-12-31 was $11.85B. Net income was -$492.0M. Revenue was down 1.3% from 2023-12-31 to 2024-12-31. W currently screens at market cap $10.77B.
BGLC currently screens at market cap $6.1M. W currently screens at market cap $10.77B.
Not investment advice. Open the BGLC and W stock pages for the full models.
Not investment advice.